Live zoster vaccine safe, effective in patients taking TNF inhibitors

ATLANTA — Data from the Varicella Zoster Vaccine study demonstrate that administering live, attenuated varicella vaccine to patients taking TNF inhibitors did not result in any safety events or disease flare after 6 weeks. In addition, there were no cases of varicella infection — either wild or vaccine type.“I’m very excited about the results of this long-planned and long in coming study,” Jeffrey Curtis, MD, a rheumatologist and clinical researcher at the University of Alabama at Birmingham, and Healio Rheumatology Peer Perspective Board member, said during aRead More

Share on facebook
Share on twitter
Share on linkedin